GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation

被引:45
作者
Dautzenberg, FM
Braun, S
Hauger, RL
机构
[1] Vet Affairs Med Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[3] F Hoffmann La Roche & Co Ltd, Div Pharma, CH-4070 Basel, Switzerland
[4] Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany
关键词
antisense; G protein-coupled receptor kinase; corticotropin-releasing factor type 1 receptor regulation; homologous and heterologous desensitization of the CRF1 receptor;
D O I
10.1152/ajpregu.2001.280.4.R935
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Potential G protein-coupled receptor kinase (GRK) and protein kinase A (PKA) mediation of homologous desensitization of corticotropin-releasing factor type 1 (CRF1) receptors was investigated in human retinoblastoma Y-79 cells. Inhibition of PKA activity by PKI5-22 or H-89 failed to attenuate homologous desensitization of CRF1 receptors, and direct activation of PKA by forskolin or dibutyryl cAMP failed to desensitize CRF-induced cAMP accumulation. However, treatment of permeabilized Y-79 cells with heparin, a nonselective GRK inhibitor, reduced homologous desensitization of CRF1 receptors by similar to 35%. Furthermore, Y-79 cell uptake of a GRK3 antisense oligonucleotide (ODN), but not of a random or mismatched ODN, reduced GRK3 mRNA expression by similar to 50% without altering GRK2 mRNA expression and inhibited homologous desensitization of CRF1 receptors by similar to 55%. Finally, Y-79 cells transfected with a GRK3 antisense cDNA construct exhibited an similar to 50% reduction in GRK3 protein expression and an similar to 65% reduction in homologous desensitization of CRF1 receptors. We conclude that GRK3 contributes importantly to the homologous desensitization of CRF1 receptors in Y-79 cells, a brain-derived cell line.
引用
收藏
页码:R935 / R946
页数:12
相关论文
共 49 条
[1]  
AHNERTHILGER G, 1965, J BIOL CHEM, V23, P12730
[2]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[3]  
ARRIZA JL, 1992, J NEUROSCI, V12, P4045
[4]  
BENOVIC JL, 1991, J BIOL CHEM, V266, P14939
[5]   BETA-ADRENERGIC-RECEPTOR KINASE - PRIMARY STRUCTURE DELINEATES A MULTIGENE FAMILY [J].
BENOVIC, JL ;
DEBLASI, A ;
STONE, WC ;
CARON, MG ;
LEFKOWITZ, RJ .
SCIENCE, 1989, 246 (4927) :235-240
[6]   G-protein-coupled receptors: turn-ons and turn-offs [J].
Carman, CV ;
Benovic, JL .
CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (03) :335-344
[7]  
CHALMERS DT, 1995, J NEUROSCI, V15, P6340
[8]   Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells [J].
Dautzenberg, FM ;
Higelin, J ;
Teichert, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 390 (1-2) :51-59
[9]   The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile [J].
Dautzenberg, FM ;
Kilpatrick, GJ ;
Wille, S ;
Hauger, RL .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :821-829
[10]   BETA-ADRENERGIC-RECEPTOR KINASE-2 AND BETA-ARRESTIN-2 AS MEDIATORS OF ODORANT-INDUCED DESENSITIZATION [J].
DAWSON, TM ;
ARRIZA, JL ;
JAWORSKY, DE ;
BORISY, FF ;
ATTRAMADAL, H ;
LEFKOWITZ, RJ ;
RONNETT, GV .
SCIENCE, 1993, 259 (5096) :825-829